In a year defined by landmark decisions, impactful announcements and new standards, clarity in the patent world comes as a welcome relief. It arrived via a federal circuit court decision in August 2024 that settled certain...more
5/13/2025
/ Appeals ,
CAFC ,
Double Patent ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Inventions ,
New Guidance ,
Obviousness-Type Double Patenting (ODP) ,
Patent Litigation ,
Patent Validity ,
Patents ,
Prior Art ,
Thought Leadership
On October 16, 2015, the Court of Appeals for the Federal Circuit (“Federal Circuit”) opted not to rehear its previously issued split decision in the court’s first analysis of the Biologics Price Competition and Innovation...more
10/21/2015
/ Amgen ,
Appeals ,
Biologics ,
Biologics Price Competition and Innovation Act of 2009 ,
Biosimilars ,
BPCIA ,
Healthcare ,
Patent Dance ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Sandoz ,
Sandoz v Amgen